The store will not work correctly when cookies are disabled.
(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(5-isobutylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288837
PubChem CID: 6474706
Max Phase: Preclinical
Molecular Formula: C18H20N2O3
Molecular Weight: 312.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(/C=C/C(=O)c2cnc(CC(C)C)cn2)ccc1O
Standard InChI: InChI=1S/C18H20N2O3/c1-12(2)8-14-10-20-15(11-19-14)16(21)6-4-13-5-7-17(22)18(9-13)23-3/h4-7,9-12,22H,8H2,1-3H3/b6-4+
Standard InChI Key: LWJHFQDVCFXRKC-GQCTYLIASA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
18.3978 -1.9480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3966 -2.7676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1047 -3.1765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8143 -2.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8115 -1.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1029 -1.5392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5177 -1.5332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2269 -1.9391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5146 -0.7160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9331 -1.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6423 -1.9337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6423 -2.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3507 -3.1557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0578 -2.7443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0521 -1.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3432 -1.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7568 -1.5092 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4675 -1.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7676 -3.1493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6886 -3.1756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6879 -3.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9799 -4.4008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3953 -4.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
17 18 1 0
14 19 1 0
2 20 1 0
20 21 1 0
21 22 1 0
21 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.37 | Molecular Weight (Monoisotopic): 312.1474 | AlogP: 3.29 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.50 | CX Basic pKa: ┄ | CX LogP: 2.94 | CX LogD: 2.94 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.65 | Np Likeness Score: 0.09 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |